1 results match your criteria: "Champalimaud Translational Centre for Eye Research L.V. Prasad Eye Institute[Affiliation]"
New Frontier in the Management of Corneal Dystrophies: Basics, Development, and Challenges in Corneal Gene Therapy and Gene Editing.
Asia Pac J Ophthalmol (Phila)
September 2022
Prof. Brien Holden Eye Research Center, Champalimaud Translational Centre for Eye Research L.V. Prasad Eye Institute, Hyderabad, India.
Article Synopsis
- * Gene therapy presents a promising solution, including strategies for gene supplementation, silencing, and editing to improve corneal health and prevent conditions like clouding and infections.
- * The CRISPR/Cas system offers potential for correcting genetic causes of corneal dystrophies but comes with challenges and limitations that need to be addressed in future studies.